Help us: Donate
Follow us on:
Ă—

Menu

Back

Blood Factors Halve Epigenetic Age in Rats

Editorial
by
May 25, 2020
Share
 0

As we previously announced, this session of Journal Club features Dr. Oliver Medvedik presenting a new study in which researchers claim that they have halved the epigenetic age of old rats using blood factors present in young rats.

CategoryJournal club, News

Tags: , ,

No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Articles

Panel Discussion of Biomarkers of Aging at EARD2020
October 23, 2020
0 Comments
In this panel discussion from Ending Age-Related Diseases 2020, Vadim Gladyshev of Harvard Medical School chairs a panel with Steve Horvath of UCLA, Kristen Fortney of BioAge Labs, Stanislav Skakun of Biodata, and Peter Fedichev of GERO to […]
Posted in: News
Tags: ,
A Genetic Footprint of Aging
October 22, 2020
0 Comments
A new analysis has revealed a core set of genes involved in aging in both humans and mice. Together with a broader set of age-related genes assembled by the study [1], this resource will serve as […]
Posted in: News
Tags: , , , ,
Generating Neural Progenitor Cells from iPSCs
October 21, 2020
0 Comments
The latest research published in the Journal of Tissue Engineering and Regenerative Medicine has reprogrammed pig fibroblast cells into neural progenitor cells.
Posted in: News
Tags: , , ,
Lifespan News – Healthier Elderly
October 20, 2020
0 Comments
  For this week’s episode of Lifespan News, Brent Nally presents an update on the state of today’s elderly, a new atlas of […]
Posted in: LifeXtenShow, News
Tags:
A New Mechanism of Telomere Lengthening in T Cells Discovered
October 20, 2020
1 Comment
An international collective of scientists has discovered a new cellular process: telomere transfer from antigen-presenting cells to T cells that boosts the latter’s lifespan and proliferative potential [1]. T cells, an important element of our adaptive immune system, […]
Posted in: News
Tags: , , ,
Using CRISPR to Remove Mutated DNA to Defeat Cancer
October 19, 2020
0 Comments
Researchers have successfully used the CRISPR/Cas9 gene editing tool to destroy Ewing’s sarcoma and chronic myeloid leukemia tumor cells by targeting the fusion genes responsible for these tumors [1]. Fusion genes, a […]
Posted in: News
Tags: , , , ,
Javier Noris Presents the Longevity Impact Fund at EARD2020
October 16, 2020
0 Comments
In his presentation at Ending Age-Related Diseases 2020, LEAF board member Javier Noris discussed the Longevity Impact Fund, the reasons why biotechnology funding has been lacking, the "valley of death" that must be crossed in order to fully fund early-stage research through the clinical trial process, and new ways in which venture capital can fund...
Posted in: News
Tags: , ,
Insilico Partners with Taisho for Senolytic Drug Discovery
October 16, 2020
1 Comment
Insilico Medicine has announced a historic deal with the Taisho Pharmaceutical Company, which is based in Japan, in a partnership to identify and develop new senolytic drugs. The companies have agreed to collaborate on […]
Posted in: News
Tags: , , , ,
Stay Connected
© 2020 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy
Terms Of Use
Powered by MMD

Want the latest longevity news? Subscribe to our Newsletter!

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.